Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
01/1999
01/05/1999US5856564 Condensed benzazepine derivative and pharmaceutical composition thereof
01/05/1999US5856509 Hypotensive agents
01/05/1999US5856503 Anticholesterol agents
01/05/1999US5856344 Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic aid, and medicament containing them
01/05/1999US5856341 Benzo B! indeno 2,1-D! thiophene compounds, intermediates, processes, compositions and methods
01/05/1999US5856336 Anticholesterol agents
01/05/1999US5856316 Mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses
01/05/1999US5856314 Thio-substituted, Nitrogen-containing, heterocyclic phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism
01/05/1999US5856169 Isolated nucleic acid
01/05/1999US5856138 Human parathyroid hormone muteins and production thereof
01/05/1999US5855920 Total hormone replacement therapy
01/05/1999US5855917 Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein comprising 20-carbon conjugated unsaturated fatty acids
01/05/1999US5855892 Administering daidzein
01/02/1999CA2221861A1 Ynl075w/htxft19
12/1998
12/30/1998WO1998058949A1 Treatment of insulin resistance with growth hormone secretagogues
12/30/1998WO1998058948A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue
12/30/1998WO1998058947A1 Dipeptide derivatives as growth hormone secretagogues
12/30/1998WO1998058938A1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
12/30/1998WO1998058934A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
12/30/1998WO1998058922A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
12/30/1998WO1998058669A2 Cd154 blockade therapy for pancreatic islet tissue transplantation
12/30/1998WO1998058658A1 Therapeutic method for management of diabetes mellitus
12/30/1998EP0887415A2 Human RCE1
12/30/1998EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor
12/30/1998EP0887349A1 Tetrahydroimidazo (2,1-a)isoquinoline derivatives
12/30/1998EP0887346A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists
12/30/1998EP0887345A1 4'-trifluoromethylbiphenyl-2-carboxylic acid-[2-(2-acetylaminoethyl)-1,2,3,4-tetrahydroisoquinolin-6-yl]amide hydrochloride as apo B-secretion/MTP inhibitors
12/30/1998EP0887081A2 Human serum glucocorticoid regulated kinase, a target for chronic renal disease
12/30/1998EP0887079A1 Beta-Adrenergic agonists to reduce a wasting condition
12/30/1998EP0886637A1 Inhibitors of microsomal triglyceride transfer protein and method
12/30/1998EP0886528A1 Use of coxiella bacteria to treat autoimmune disease
12/30/1998EP0686164B1 Intrinsic inhibitors of aldose reductase
12/30/1998EP0623112B1 4-Phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
12/30/1998EP0584175B1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual
12/30/1998CN1203529A 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor
12/30/1998CN1203528A Use of gamma-RAR-specific agonist ligand to increase apoptosis rate
12/30/1998CN1203228A Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
12/30/1998CN1203037A Composition and method for providing nutrition to diabetics
12/30/1998CA2294601A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
12/30/1998CA2294464A1 Treatment of insulin resistance
12/30/1998CA2294169A1 Therapeutic method for management of diabetes mellitus
12/30/1998CA2294154A1 Cd154 blockade therapy for pancreatic islet tissue transplantation
12/29/1998US5854292 Stimulating the differentiation of preadipocytic cells and therapies based thereon
12/29/1998US5854289 Guanylhydrazones and their use to treat inflammatory conditions
12/29/1998US5854272 2-alkylpyrrolidines
12/29/1998US5854255 Therapeutic package for the long term reduction of body fat stores insulin resistance hyperinsulinemia and hyperglycemia in vertebrates
12/29/1998US5854234 Amidino dervatives useful as nitric oxide synthase inhibitors
12/29/1998US5854211 Compounds with growth hormone releasing properties
12/29/1998US5854208 Hepatoselective pharmaceutical actives
12/29/1998US5853748 Pharmaceutical compositions
12/29/1998US5853723 Targeting of peg antibody conjugates to islet cells
12/29/1998US5853703 Preventing and reversing the formation of advanced glycosylation endproducts
12/29/1998CA2017692C Carboxamide derivatives
12/29/1998CA1340295C Human somatomedin carrier protein subunits and process for procucing them
12/27/1998CA2234417A1 Human serum glucocorticoid regulated kinase, a target for chronic renal disease
12/24/1998DE19725799A1 Use of substituted thio-phenoxy derivatives
12/24/1998DE19722846A1 Leukotrien-B¶4¶-Derivate, insbesondere 7-Methylcyclohexyl-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular 7-methylcyclohexyl-LTB¶4¶ antagonists
12/24/1998CA2234402A1 Human rce1
12/23/1998WO1998057987A2 Irs-p53h, human insulin receptor tyrosine kinase substrate
12/23/1998WO1998057966A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998WO1998057941A1 New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
12/23/1998WO1998057940A1 Heterocyclic substituted piperidines and uses thereof
12/23/1998WO1998057936A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/23/1998WO1998057919A1 Selective thyroid hormone analogs
12/23/1998WO1998057917A1 METHOD FOR PRODUCING MEDICAMENTS CONTAINING HMG-CoA-REDUCTASE INHIBITORS
12/23/1998WO1998057656A1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor
12/23/1998WO1998057652A1 Polyallylamine polymers for treating hypercholesterolemia
12/23/1998WO1998057649A1 Treatment of diabetes with thiazolidinedione and sulphonylurea
12/23/1998WO1998057636A1 Treatment of diabetes with rosiglitazone and insulin
12/23/1998WO1998057635A1 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
12/23/1998WO1998057634A1 Treatment of diabetes with thiazolidinedione and metformin
12/23/1998WO1998057622A1 Synergistic compositions for lycopene and vitamin e for the prevention of ldl oxidation
12/23/1998EP0885960A2 G-protein coupled receptor (H7TBA62)
12/23/1998EP0885299A1 Wsx receptor and ligands
12/23/1998CN1202904A Cyclopeptolides
12/23/1998CN1202893A Novel isoxazoline and isoxazole fibrinogen deceptor antagonists
12/23/1998CN1202886A 3-spiro-indolin-2-one derivatives, its preparing method and its medicinal compounds
12/23/1998CN1202825A Protein kinase C inhibitor
12/23/1998CN1202823A Hydrolysis-optimized liplid emulsions and use thereof
12/23/1998CA2698626A1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor
12/23/1998CA2549864A1 Treatment of diabetes with thiazolidinedione and metformin
12/23/1998CA2430623A1 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
12/23/1998CA2294724A1 Method for producing medicaments containing hmg-coa-reductase inhibitors
12/23/1998CA2294549A1 Heterocyclic substituted piperidines and uses thereof
12/23/1998CA2294141A1 Treatment of diabetes with rosiglitazone and insulin
12/23/1998CA2294137A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998CA2294134A1 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
12/23/1998CA2293998A1 Irs-p53h, human insulin receptor tyrosine kinase substrate
12/23/1998CA2293449A1 New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
12/23/1998CA2289100A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/23/1998CA2241164A1 Apo b-secretion/mtp inhibitor hydrochloride salt
12/22/1998US5852210 Cinnamic acid derivatives
12/22/1998US5852059 Use of droloxifene for the treatment of protastic disease, endometriosis and obesity
12/22/1998US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/22/1998US5852007 Cysteine and serine protease inhibitors containing D-amino acid at the P2 position, methods of making same, and methods of using same
12/22/1998US5851999 FLK-1 is a receptor for vascular endothelial growth factor
12/22/1998US5851995 Anti-obesity proteins
12/22/1998US5851986 Promoting bone formation and inhibiting bone resorption with high mobility group protein-1 (HMG-1)
12/22/1998US5851814 Human elastate IV
12/22/1998US5851518 Polymeric compositions
1 ... 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 ... 1298